Nymox Pharma files amended annual report on Form 20-F/A for 2025

Bitget2026/09/29 21:28

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Nymox Pharmaceutical Corporation published a revised annual report for the year ended Dec. 31, 2025.
The filing corrected the date of M&K CPAS, PLLC’s independent audit report to Sept. 11, 2026.
No other changes were made to the annual report beyond updated signature, certification, and exhibit items.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nymox Pharmaceutical Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001640334-26-001603), on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Nymox Pharma files amended annual report on Form 20-F/A for 2025

You may also like

Crypto prices